Merck Tbk. vs Putra Mandiri Jembar Tbk. — how do they compare? Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume), while Putra Mandiri Jembar Tbk. trades at Rp109 (market cap 1.5T, 345.5K 24h volume). The key difference: Merck Tbk. and Putra Mandiri Jembar Tbk. are close in size by market cap, and Putra Mandiri Jembar Tbk. is more actively traded (345.5K versus 37.6K). Which is the better fit depends on your goals.
| MERK | PMJS | |
|---|---|---|
Market Cap | 1.7T | 1.5T |
Volume | 37.6K | 345.5K |
Lot | 376 | 3.46K |
Turnover | 144.47M | 36.98M |
Average Price | 3,842.23 | 107.05 |
Value | 144.47M | 36.98M |
Indicative Equilibrium Price | 3,840 | 109 |
Indicative Equilibrium Volume | 7 | 4.2K |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →PT Putra Mandiri Jembar Tbk (the Company) was domiciled in Jakarta, established under the Deed No. 52 dated 18 July 2003 by notary Arikanti Natakusumah, S.H. PT Pahalamas Sejahtera is the parent entity and ultimate holding of the Company.
Read more on PMJS →